STEPHANIE DEVEAU: Open Payments
NPI 1649000654 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $749 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $154 |
| Averitas Pharma Inc. | 2 | $62 |
| Valinor Pharma, LLC | 2 | $44 |
| Lundbeck LLC | 1 | $32 |
| TerSera Therapeutics LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
Products named: RELISTOR, QUTENZA, MOVANTIK, VYEPTI, Prialt, ZEPBOUND.
Industry payments across MA — which companies pay providers there.
